{"id":"https://openalex.org/W4291992171","doi":null,"title":"Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.","display_name":"Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.","alternate_titles":[],"publication_year":2005,"publication_date":"2005-08-01","ids":{"openalex":"https://openalex.org/W4291992171","pmid":"https://pubmed.ncbi.nlm.nih.gov/16106596"},"language":"en","primary_location":{"id":"pmid:16106596","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16106596","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prescrire international","raw_type":"Comparative Study"},"parent_works":[],"lineage":["https://openalex.org/W4291992171"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1535,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.53098102,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"14","issue":"78","first_page":"140","last_page":"142"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.996999979019165},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9800000190734863},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.8579999804496765},{"id":"https://openalex.org/keywords/lithium","display_name":"lithium","score":0.8899999856948853},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8169999718666077},{"id":"https://openalex.org/keywords/mood-stabilizers","display_name":"mood stabilizers","score":0.5799999833106995},{"id":"https://openalex.org/keywords/trial-dropout","display_name":"trial dropout","score":0.3630000054836273},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6200000047683716},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.9049999713897705},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hyperglycemia","display_name":"hyperglycemia","score":0.8870000243186951},{"id":"https://openalex.org/keywords/ketoacidosis","display_name":"ketoacidosis","score":0.7360000014305115},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.6909999847412109},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.5070000290870667},{"id":"https://openalex.org/keywords/suicide-risk","display_name":"suicide risk","score":0.44699999690055847}],"concepts":[{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8976904153823853},{"id":"https://openalex.org/C2776809841","wikidata":"https://www.wikidata.org/wiki/Q185935","display_name":"Mania","level":4,"score":0.6881365180015564},{"id":"https://openalex.org/C2778541603","wikidata":"https://www.wikidata.org/wiki/Q152763","display_name":"Lithium (medication)","level":2,"score":0.6333134770393372},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.6296095848083496},{"id":"https://openalex.org/C2780550438","wikidata":"https://www.wikidata.org/wiki/Q2622367","display_name":"Mood stabilizer","level":4,"score":0.6275193095207214},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6057648658752441},{"id":"https://openalex.org/C2778609679","wikidata":"https://www.wikidata.org/wiki/Q4915474","display_name":"Bipolar I disorder","level":5,"score":0.5484040379524231},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4884723722934723},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47949057817459106},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4446747601032257},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.41209203004837036},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.3698574900627136},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.18294724822044373},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001714","descriptor_name":"Bipolar Disorder","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008094","descriptor_name":"Lithium","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008094","descriptor_name":"Lithium","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008094","descriptor_name":"Lithium","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":1,"locations":[{"id":"pmid:16106596","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16106596","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Prescrire international","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2049639028","https://openalex.org/W1593754392","https://openalex.org/W1999594051","https://openalex.org/W2264935484","https://openalex.org/W2149239840","https://openalex.org/W2101162312","https://openalex.org/W7220375005","https://openalex.org/W1990721010","https://openalex.org/W2136125265"],"abstract_inverted_index":{"(1)":[0],"Lithium,":[1],"the":[2,12,22,96,142,146,161,219,283,286,298,316,350,379],"standard":[3,351],"preventive":[4],"treatment":[5,178,237,262,352],"for":[6,30,44,90,185,271,353],"patients":[7,35,65,87,130,140,149,170,217,250,311],"with":[8,36,122,179,188,212,229,232,263,312,331],"bipolar":[9,37,313,356],"disorder,":[10],"reduces":[11],"number":[13],"of":[14,32,148,207,236,276,308,320,381],"relapses":[15,152,205],"and":[16,145,203,325,335],"suicide":[17,239],"attempts.":[18],"(2)":[19],"Olanzapine":[20,328],"is":[21,359,365],"first":[23],"neuroleptic":[24],"to":[25,80,108,210,225,293],"be":[26,106],"approved":[27],"in":[28,34,54,128,171,200,251,268,310],"France":[29],"prevention":[31,307],"relapse":[33,277,309],"disorder.":[38,357],"Many":[39],"neuroleptics":[40],"are":[41],"already":[42],"used":[43],"this":[45],"indication":[46],"but":[47,84,214,285],"their":[48,260],"efficacy":[49,380],"has":[50],"not":[51,157,242,279,297],"been":[52],"established":[53],"comparative":[55],"clinical":[56],"trials.":[57],"(3)":[58],"One":[59,113],"placebo-controlled":[60],"double-blind":[61,114,167,269],"trial":[62,77,97,115,193],"involved":[63],"361":[64],"who":[66,131,150],"were":[67,88,183,223,300],"treated":[68,89,184],"just":[69],"after":[70,177,372],"recovering":[71],"from":[72,134,173,253],"a":[73,119,125,165,174,246,254,369],"manic":[74,175,204,257],"episode.":[75,137],"The":[76,234,274],"was":[78,197,241,278,290,329],"supposed":[79],"last":[81],"48":[82],"weeks,":[83],"only":[85,215],"146":[86],"more":[91,198,332,366],"than":[92,337,368],"8":[93],"weeks.":[94],"Therefore,":[95],"results,":[98],"including":[99,322],"an":[100,135],"observed":[101],"effect":[102],"on":[103,238,306,341],"mania,":[104],"cannot":[105],"interpreted":[107],"imply":[109],"long-term":[110],"prevention.":[111],"(4)":[112],"compared":[116,209],"olanzapine":[117,180,196,264,342,364],"plus":[118,124],"mood":[120,126,370],"stabiliser":[121,127,371],"placebo":[123],"344":[129],"had":[132,151],"recovered":[133],"acute":[136],"Only":[138],"21":[139],"completed":[141,218],"12-month":[143],"trial,":[144,168],"percentage":[147],"(manic":[153],"or":[154,190,256,265,296,375],"depressive)":[155],"did":[156],"differ":[158],"significantly":[159,280],"between":[160,282],"groups.":[162],"(5)":[163],"In":[164,245],"third":[166],"431":[169],"remission":[172,252],"episode":[176,258],"+":[181],"lithium":[182,189,373],"12":[186],"months":[187],"olanzapine.":[191],"This":[192],"suggested":[194],"that":[195,363,376],"effective":[199,367],"preventing":[201,354],"depressive":[202],"(30%":[206],"patients,":[208],"38.8%":[211],"lithium),":[213],"171":[216],"trial.":[220],"Most":[221],"dropouts":[222],"due":[224],"adverse":[226,318],"events":[227],"(19%":[228],"olanzapine,":[230,321],"26%":[231],"lithium).":[233],"impact":[235],"risk":[240,275],"studied.":[243],"(6)":[244],"fourth":[247],"study,":[248],"101":[249],"mixed":[255],"continued":[259],"initial":[261],"sodium":[266],"divalproate":[267],"manner":[270],"11":[272],"months.":[273],"different":[281],"groups,":[284],"study":[287],"sample":[288],"size":[289],"too":[291],"small":[292],"tell":[294],"whether":[295],"treatments":[299],"equally":[301],"effective.":[302],"(7)":[303],"Trials":[304],"focusing":[305],"disorder":[314],"confirmed":[315],"known":[317],"effects":[319],"weight":[323,333],"gain":[324,334],"QTc":[326],"prolongation.":[327],"associated":[330],"sedation":[336],"lithium.":[338,382],"Hyperglycaemia":[339],"occurring":[340],"can":[343],"cause":[344],"life-threatening":[345],"ketoacidosis.":[346],"(8)":[347],"Lithium":[348],"remains":[349],"recurrent":[355],"There":[358],"no":[360],"firm":[361],"evidence":[362],"failure,":[374],"it":[377],"boosts":[378]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4291992171","counts_by_year":[],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2022-08-16T00:00:00"}
